SEARCH

SEARCH BY CITATION

References

  • 1
    Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977; 50: 48192.
  • 2
    Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79: 20315.
  • 3
    Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-1 associated myelopathy, a new clinical entity. Lancet 1986; 1: 10312.
  • 4
    Yamaguchi K, Watanabe T. Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. Int J Hematol 2002; 76: 2405.
  • 5
    Popovic M, Sarin PS, Robert-Gurroff M, Kalyanaraman VS, Mann D, Minowada J, Gallo RC. Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science 1983; 219: 8569.
  • 6
    Derse D, Hill SA, Lloyd PA, Chung HK, Morse BA. Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors. J Virol 2001; 75: 84618.
  • 7
    Etoh K, Tamiya S, Yamaguchi K, Okayama A, Tsubouchi H, Ideta T, Mueller N, Takatsuki K, Matsuoka M. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res 1997; 57: 48627.
  • 8
    Cavrois M, Leclercq I, Gout O, Gessain A, Wain-Hobson S, Wattel E. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene 1998; 17: 7782.
  • 9
    Lairmore MD, Silverman L, Ratner L. Animal models for human T-lymphotropic virus type 1(HTLV-1) infection and transformation. Oncogene 2005; 24: 600515.
  • 10
    Greiner DL, Shultz LD, Yates J, Appel MC, Perdrizet G, Hesselton RM, Schweitzer I, Beamer WG, Shultz KL, Pelsue SC. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol 1995; 146: 888902.
  • 11
    Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, Mckenna S, Mobraaten L, Rajan TV, Greiner DL. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995; 154: 18091.
  • 12
    Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaki H, Hisakawa H, Mitsui T, Manabe A, Tanaka R, Kobayashi K, Ito M, Yasukawa K, et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor. Flk2/Flt3 ligand, thrombopoietin, l. L-6, and soluble l. L-6 receptor. J Clin Invest 2000; 105: 8556.
  • 13
    Koyanagi Y, Tanaka Y, Tanaka R, Misawa N, Kawano Y, Tanaka I, Miyasaka M, Ito M, Ueyama Y, Yamamoto N. High levels of viremia in hu-PBL-NOD-scid mice with HIV-1 infection. Leukemia 1997; 11: 10912.
  • 14
    Christianson SW, Greiner DL, Hesselton RA, Leif JH, Waqar EJ, Schweitzer IB, Rajan TV, Gott B, Roopenian DC, Shultz LD. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol 1997; 158: 357886.
  • 15
    Kollet O, Peled A, Byk T, Ben-Hur H, Greiner D, Shultz L, Lapidot T. β2 Microglobulin-deficient (β2mnull) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 2000; 95: 31025.
  • 16
    Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T. NOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 317582.
  • 17
    Dewan MZ, Terashima K, Taruishi M, Hasegawa H, Ito M, Tanaka Y, Mori N, Sata T, Koyanagi Y, Maeda M, Kubuki Y, Okayama A, et al. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/γcnull mice: suppression by an inhibitor against NF-kB. J Virol 2003; 77: 528694.
  • 18
    Dewan MZ, Uchihara J, Terashima K, Honda M, Sata T, Ito M, Fujii N, Uozumi K, Tsukasaki K, Tomonaga M, Kubuki Y, Okayama A, et al. Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir. Blood 2006; 107: 71624.
  • 19
    Kawano N, Ishikawa F, Shimoda K, Yasukawa M, Nagafuji K, Miyamoto T, Baba E, Tanaka T, Yamasaki S, Gondo H, Otsuka T, Ohshima K, et al. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/β2-microglobulinnull mice. Leukemia 2005; 19: 138490.
  • 20
    Miyazato P, Yasunaga J, Taniguchi Y, Koyanagi Y, Mitsuya H, Matsuoka M. De novo HTLV-1 infection of human lymphocytes in nonobese diabetic-SCID, common γ-chain knocked-out mice. J Virol. 2006; 80: 1068391.
  • 21
    Sambrook J, Russell DW. Molecular cloning: A laboratory manual, 3rd edn. New York: Cold Spring Harbor Laboratory Press, 2001.
  • 22
    Tanaka G, Okayama A, Watanabe T, Aizawa S, Stuver S, Mueller N, Hsieh CC, Tsubouchi H. The clonal expansion of human T lymphotropic virus type 1-infected T cells: A comparison between seroconverters and long-term carrires. J Infect Dis 2005; 191: 11407.
  • 23
    Dehee A, Cesaire R, Desire N, Lezin A, Bourdonne O, Bera O, Plumelle Y, Smadja D, Nicolas JC. Quantitation of HTLV-1 proviral load by a TaqMan real-time PCR assay. J Virol Methods. 2002; 102: 3751.
  • 24
    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 1569.
  • 25
    Okayama A, Stuver S, Matsuoka M, Ishizaki J, Tanaka G, Kubuki Y, Mueller N, Hsieh C, Tachibana N, Tsubouchi H. Role of HTLV-1 Proviral DNA Load and Clonality in the Development of Adult T-Cell Leukemia/Lymphoma in Asymptomatic Carriers. Int J Cancer. 2004; 110: 6215.
  • 26
    Franchini G, Fukumoto R, Fullen JR. T-cell control by human T-cell leukemia/lymphoma virus type 1. Inf J Hematol 2003; 78: 28096.
  • 27
    Grassmann R, Aboud M, Jeang KT. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 2005; 24: 597685.
  • 28
    Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001; 19: 47596.
  • 29
    Matsumura T, Kametani Y, Ando K, Hirano Y, Katano I, Ito R, Shiina M, Tsukamoto H, Saito Y, Tokuda Y, Kato S, Ito M, et al. Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/ γcnull (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells. Exp Hematol 2003; 31: 78997.
  • 30
    Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner DL, Handgretinger R. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005; 174: 647789.
  • 31
    Okayama A, Tachibana N, Ishihara S, Nagatomo Y, Murai K, Okamoto M, Shima T, Sagawa K, Tsubouchi H, Stuver S, Mueller N. Increased expression of interleukin-2 receptor α on peripheral blood mononuclear cells in HTLV-1 tax/rex mRNA-positive asymptomatic carriers. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 705.
  • 32
    Kinoshita T, Shimoyama M, Tobinai K, Ito M, Ito S, Ikeda S, Tajima K, Shimotohno K, Sugimura T. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 56204.
  • 33
    Kawano N, Shimoda K, Ishikawa F, Taketomi A, Yoshizumi T, Shimoda S, Yoshida S, Uozumi K, Suzuki S, Maehara Y, Harada M. Adult T-cell leukemia development from a human T-cell leukemia virus type 1 carrier after a living-donor liver transplantation. Transplantation 2006; 82: 8403.